Concise route to α-acylamino-β-keto amides: application to the synthesis of a simplified azinomycin A analogue
摘要:
Condensation of acid chlorides (alkyl, aryl or heteroaryl) with N,N'-dialkyl alpha-acylamino malonamides in the presence of magnesium ethoxide provides a direct route to alpha-acylamino-beta-keto amides in moderate to good yields (46-95%). Using this method, a concise route to an enantiomerically enriched 1-azabicyclo[3.1.0]hexane containing most of the elements of the 'right-hand' domain of azinomycin A has been developed. (C) 2002 Elsevier Science Ltd. All rights reserved.
Amidomalonamides useful as inhibitors of MMP of matrix metalloproteinase
申请人:Aventis Pharmaceuticals Inc.
公开号:US06329550B1
公开(公告)日:2001-12-11
The present application relates to novel aminomalonamides of the formula
and pharmaceutical composition thereof which are useful for inhibiting matrix metalloproteinases.
本申请涉及以下结构的新型氨基丙二酰胺及其药物组合物,可用于抑制基质金属蛋白酶。
US6329550B1
申请人:——
公开号:US6329550B1
公开(公告)日:2001-12-11
[EN] AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE<br/>[FR] AMIDOMALONAMIDES ET LEURS UTILISATIONS COMME INHIBITEURS DES METALLOPROTEINASES MATRICIELLES
申请人:AVENTIS PHARMA INC
公开号:WO2000040552A1
公开(公告)日:2000-07-13
The present application relates to novel aminomalonamides of formula (1) and pharmaceutical composition thereof which are useful for inhibiting matrix metallo-proteinases.
AMIDOMALONAMIDES AND THEIR USE AS INHIBITORS OF MATRIX METALLOPROTEINASE
申请人:Aventis Pharmaceuticals Inc.
公开号:EP1140818B1
公开(公告)日:2003-09-10
Concise route to α-acylamino-β-keto amides: application to the synthesis of a simplified azinomycin A analogue
作者:Jean-Yves Goujon、Michael Shipman
DOI:10.1016/s0040-4039(02)02420-6
日期:2002.12
Condensation of acid chlorides (alkyl, aryl or heteroaryl) with N,N'-dialkyl alpha-acylamino malonamides in the presence of magnesium ethoxide provides a direct route to alpha-acylamino-beta-keto amides in moderate to good yields (46-95%). Using this method, a concise route to an enantiomerically enriched 1-azabicyclo[3.1.0]hexane containing most of the elements of the 'right-hand' domain of azinomycin A has been developed. (C) 2002 Elsevier Science Ltd. All rights reserved.